{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:03:17Z","timestamp":1791572597238,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jtct.2026.04.018","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:11:29Z","timestamp":1776384689000},"page":"980.e1-980.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Are HLA-Haploidentical Relatives a Donor Choice for Patients With Severe Aplastic Anemia? A GATMO-TC Experience"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9892-5543","authenticated-orcid":false,"given":"Ana Lisa","family":"Basquiera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0552-444X","authenticated-orcid":false,"given":"Mariano","family":"Berro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8589-799X","authenticated-orcid":false,"given":"Gonzalo","family":"Bentolila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Sol","family":"Jarchum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Cerutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3715-7115","authenticated-orcid":false,"given":"Patricio","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Milone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvina","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Cruset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3158-9657","authenticated-orcid":false,"given":"Pablo","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Emilia","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2367-6161","authenticated-orcid":false,"given":"Jorge Alberto","family":"Arbelbide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Laura","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2555-6673","authenticated-orcid":false,"given":"Gregorio","family":"Jaimovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jtct.2026.04.018_bib0001","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1182\/blood-2006-03-010777","article-title":"Current concepts in the pathophysiology and treatment of aplastic anemia","volume":"108","author":"Young","year":"2006","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtct.2026.04.018_bib0002","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM198203183061105","article-title":"Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis","volume":"306","author":"Camitta","year":"1982","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jtct.2026.04.018_bib0003","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJM198203253061204","article-title":"Aplastic anemia (second of two parts): pathogenesis, diagnosis, treatment, and prognosis","volume":"306","author":"Camitta","year":"1982","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jtct.2026.04.018_bib0004","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5045\/kjh.2012.47.2.126","article-title":"Should we still use Camitta\u2019s criteria for severe aplastic anemia?","volume":"47","author":"Yoon","year":"2012","journal-title":"Korean J Hematol"},{"issue":"4","key":"10.1016\/j.jtct.2026.04.018_bib0005","first-page":"219","article-title":"Aplastic anemia: clinicohaematological features, treatment and outcome analysis","volume":"21","author":"Wali","year":"2011","journal-title":"J Coll Physicians Surg Pak"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.018_bib0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa2109965","article-title":"Eltrombopag added to immunosuppression in severe aplastic anemia","volume":"386","author":"Peffault de Latour","year":"2022","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jtct.2026.04.018_bib0007","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00277-017-3136-1","article-title":"Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naive aplastic anemia: a systematic review and meta-analysis","volume":"96","author":"Yang","year":"2017","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.018_bib0008","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41408-024-01021-x","article-title":"Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia","volume":"14","author":"Wu","year":"2024","journal-title":"Blood Cancer J"},{"issue":"5","key":"10.1016\/j.jtct.2026.04.018_bib0009","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJMoa1103975","article-title":"Horse versus rabbit antithymocyte globulin in acquired aplastic anemia","volume":"365","author":"Scheinberg","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.018_bib0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1200\/JCO.22.00710","article-title":"Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria","volume":"41","author":"Gurnari","year":"2023","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jtct.2026.04.018_bib0011","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bjh.13614","volume":"171","author":"Dufour","year":"2015","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.jtct.2026.04.018_bib0012","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3324\/haematol.2014.115345","article-title":"Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis","volume":"100","author":"Bacigalupo","year":"2015","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.jtct.2026.04.018_bib0013","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.3324\/haematol.2023.282781","article-title":"Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy","volume":"108","author":"Nakamura","year":"2023","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.018_bib0014","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/bmt.2016.223","article-title":"Immunosuppressive therapy versus alternative donor hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched familial donor","volume":"52","author":"Choi","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.04.018_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217594","article-title":"Comparable survival outcomes in HLA-matched and haploidentical hematopoietic stem cell transplantation for severe aplastic anemia patients aged 40-50: a CBMTR registry-based propensity score matching analysis over the last decade","volume":"621","author":"Xu","year":"2025","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.018_bib0016","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jtct.2025.10.021","article-title":"Long-term follow-up of the Baltimore experience with hematopoietic cell transplantation for severe aplastic anemia using post-transplantation cyclophosphamide","volume":"32","author":"DeZern","year":"2026","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.jtct.2026.04.018_bib0017","first-page":"900","article-title":"Comparison of haploidentical-hematopoietic stem cell transplantation using modified post-transplantation cyclophosphamide and eltrombopag combined with immunosuppression for the treatment of severe aplastic anemia","volume":"31","author":"Fu","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.jtct.2026.04.018_bib0018","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00277-023-05256-9","article-title":"Comparison of haploidentical-allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study","volume":"102","author":"Wu","year":"2023","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.jtct.2026.04.018_bib0019","first-page":"105","volume":"28","author":"Alotaibi","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2026.04.018_bib0020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jtct.2026.04.018_bib0021","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1182\/bloodadvances.2018028662","article-title":"Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis","volume":"3","author":"Barker","year":"2019","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.jtct.2026.04.018_bib0022","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41409-024-02251-0","article-title":"Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT","volume":"59","author":"Sureda","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.04.018_bib0023","first-page":"2305","article-title":"Graft-versus-host disease and relapse\/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT","volume":"108","author":"Devillier","year":"2023","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.018_bib0024","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.04.018_bib0025","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jclinepi.2010.11.012","article-title":"Performance of logistic regression modeling: beyond the number of events per variable, the role of data structure","volume":"64","author":"Courvoisier","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.018_bib0026","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3324\/haematol.10075","article-title":"Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT)","volume":"92","author":"Locasciulli","year":"2007","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.jtct.2026.04.018_bib0027","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1016\/S2352-3026(22)00206-X","article-title":"Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial","volume":"9","author":"DeZern","year":"2022","journal-title":"Lancet Haematol"},{"issue":"8","key":"10.1016\/j.jtct.2026.04.018_bib0028","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/bloodadvances.2020001729","article-title":"Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide","volume":"4","author":"DeZern","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.018_bib0029","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood.2024024173","article-title":"Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT","volume":"144","author":"Montoro","year":"2024","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtct.2026.04.018_bib0030","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/s41409-020-0897-2","volume":"55","author":"ElGohary","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.018_bib0031","first-page":"199","volume":"29","author":"Kharya","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.jtct.2026.04.018_bib0032","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3324\/haematol.2011.054841","article-title":"Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups","volume":"97","author":"Bacigalupo","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2026.04.018_bib0033","article-title":"Peripheral blood stem cell transplantation vs. bone marrow transplantation for aplastic anemia: a systematic review and meta-analysis","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.jtct.2026.04.018_bib0034","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/bmt.2016.212","article-title":"The Latin American experience of allografting patients with severe aplastic anaemia: real-world data on the impact of stem cell source and ATG administration in HLA-identical sibling transplants","volume":"52","author":"Gomez-Almaguer","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.04.018_bib0035","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41409-025-02750-8","article-title":"Unrelated donor transplantation for relapsed refractory aplastic anemia, with quadruple GvHD prophylaxis","volume":"61","author":"Giammarco","year":"2026","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.04.018_bib0036","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.bbmt.2017.05.026","volume":"23","author":"Park","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"10.1016\/j.jtct.2026.04.018_bib0037","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1182\/bloodadvances.2019000722","article-title":"Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia","volume":"3","author":"Bejanyan","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.018_bib0038","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12185-022-03487-6","article-title":"Outcome of peripheral blood stem cell transplantation from HLA-identical sibling donors for adult patients with aplastic anemia","volume":"117","author":"Nakamura","year":"2023","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2026.04.018_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102819","article-title":"Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study","volume":"76","author":"Eapen","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jtct.2026.04.018_bib0040","article-title":"Comparison of hematopoietic stem cell transplantation outcomes using matched sibling donors, haploidentical donors, and immunosuppressive therapy for patients with acquired aplastic anemia","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.jtct.2026.04.018_bib0041","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.3324\/haematol.2022.280758","article-title":"Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study","volume":"107","author":"Xu","year":"2022","journal-title":"Haematologica"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726003064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726003064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:37:01Z","timestamp":1785415021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726003064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666636726003064"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.04.018","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are HLA-Haploidentical Relatives a Donor Choice for Patients With Severe Aplastic Anemia? A GATMO-TC Experience","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}